Rb. Gherman et Tm. Goodwin, Obstetric implications of activated protein C resistance and factor V leiden Mutation, OB GYN SURV, 55(2), 2000, pp. 117-122
An increasing number of reports have focused on activated protein C resista
nce (APCR) as it has been shown not only to be the most common genetic fact
or predisposing patients to thromboembolic disease but the most common iden
tifiable cause overall. More than 90 percent of the cases of APCR are cause
d by the factor V Leiden mutation, in which a guanine to adenine substituti
on in the factor V gene at nucleotide position 1691 results in a glutamine
to arginine switch at position 506, Recent studies have also pointed to evi
dence of an association between APOR/factor V Leiden mutation and hypertens
ive disorders of pregnancy, first and second trimester miscarriage, placent
al infarction, and placental abruption.